Differences between African-American adolescent females with and without human papillomavirus infection

Puja Seth, Gina M. Wingood, Ralph DiClemente, Richard A. Crosby, Laura F. Salazar, Eve S. Rose, Jessica M. Sales

Research output: Contribution to journalArticle

Abstract

Background: An important policy question is whether high-risk populations can be identified and prioritised for human papillomavirus (HPV) immunisation. Methods: Data collection included an audio computer-assisted survey interview and testing of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and HPV among 295 African-American adolescent females. Results: The results indicated that 43.1% tested positive for HPV. Logistic regression analyses indicated that HPV prevalence was not associated with other sexually transmissible infections (prevalence ratio (PR)=0.85, 95% confidence interval (CI)=0.51-1.41), unprotected vaginal sex (PR=1.04, 95% CI=0.56-1.92), having sex with an older male partner (PR=1.12, 95% CI=0.64-1.96), and having a casual partner (PR=0.89, 95% CI=0.54-1.48). Additionally, t-tests indicated that HPV prevalence was not associated with frequency of vaginal sex (t=0.17, P=0.87), protected sex (t=0.16, P=0.87), number of recent (t=0.40, P=0.69) or lifetime (t=1.45, P=0.15) sexual partners. However, those testing positive for HPV were younger (t=1.97, P=0.05) and reported current use of birth control pills (PR=2.38, 95% CI=1.00-5.63). Conclusions: It may not be possible to identify those with elevated risk of HPV acquisition. Thus, HPV vaccination, regardless of risk indicators, may be the most efficacious public health strategy.

Original languageEnglish (US)
Pages (from-to)125-127
Number of pages3
JournalSexual Health
Volume8
Issue number1
DOIs
StatePublished - Feb 3 2011

Fingerprint

Papillomavirus Infections
African Americans
Confidence Intervals
Safe Sex
Unsafe Sex
Trichomonas vaginalis
Neisseria gonorrhoeae
Sexual Partners
Chlamydia trachomatis
Sex Ratio
Contraception
Immunization
Vaccination
Public Health
Logistic Models
Regression Analysis
Interviews
Infection

Keywords

  • adolescents
  • African-American
  • human papillomavirus

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Seth, P., Wingood, G. M., DiClemente, R., Crosby, R. A., Salazar, L. F., Rose, E. S., & Sales, J. M. (2011). Differences between African-American adolescent females with and without human papillomavirus infection. Sexual Health, 8(1), 125-127. https://doi.org/10.1071/SH10107

Differences between African-American adolescent females with and without human papillomavirus infection. / Seth, Puja; Wingood, Gina M.; DiClemente, Ralph; Crosby, Richard A.; Salazar, Laura F.; Rose, Eve S.; Sales, Jessica M.

In: Sexual Health, Vol. 8, No. 1, 03.02.2011, p. 125-127.

Research output: Contribution to journalArticle

Seth, P, Wingood, GM, DiClemente, R, Crosby, RA, Salazar, LF, Rose, ES & Sales, JM 2011, 'Differences between African-American adolescent females with and without human papillomavirus infection', Sexual Health, vol. 8, no. 1, pp. 125-127. https://doi.org/10.1071/SH10107
Seth, Puja ; Wingood, Gina M. ; DiClemente, Ralph ; Crosby, Richard A. ; Salazar, Laura F. ; Rose, Eve S. ; Sales, Jessica M. / Differences between African-American adolescent females with and without human papillomavirus infection. In: Sexual Health. 2011 ; Vol. 8, No. 1. pp. 125-127.
@article{7bf9fec7893045f9a7ffe6f3c4a2053a,
title = "Differences between African-American adolescent females with and without human papillomavirus infection",
abstract = "Background: An important policy question is whether high-risk populations can be identified and prioritised for human papillomavirus (HPV) immunisation. Methods: Data collection included an audio computer-assisted survey interview and testing of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and HPV among 295 African-American adolescent females. Results: The results indicated that 43.1{\%} tested positive for HPV. Logistic regression analyses indicated that HPV prevalence was not associated with other sexually transmissible infections (prevalence ratio (PR)=0.85, 95{\%} confidence interval (CI)=0.51-1.41), unprotected vaginal sex (PR=1.04, 95{\%} CI=0.56-1.92), having sex with an older male partner (PR=1.12, 95{\%} CI=0.64-1.96), and having a casual partner (PR=0.89, 95{\%} CI=0.54-1.48). Additionally, t-tests indicated that HPV prevalence was not associated with frequency of vaginal sex (t=0.17, P=0.87), protected sex (t=0.16, P=0.87), number of recent (t=0.40, P=0.69) or lifetime (t=1.45, P=0.15) sexual partners. However, those testing positive for HPV were younger (t=1.97, P=0.05) and reported current use of birth control pills (PR=2.38, 95{\%} CI=1.00-5.63). Conclusions: It may not be possible to identify those with elevated risk of HPV acquisition. Thus, HPV vaccination, regardless of risk indicators, may be the most efficacious public health strategy.",
keywords = "adolescents, African-American, human papillomavirus",
author = "Puja Seth and Wingood, {Gina M.} and Ralph DiClemente and Crosby, {Richard A.} and Salazar, {Laura F.} and Rose, {Eve S.} and Sales, {Jessica M.}",
year = "2011",
month = "2",
day = "3",
doi = "10.1071/SH10107",
language = "English (US)",
volume = "8",
pages = "125--127",
journal = "Sexual Health",
issn = "1448-5028",
publisher = "CSIRO",
number = "1",

}

TY - JOUR

T1 - Differences between African-American adolescent females with and without human papillomavirus infection

AU - Seth, Puja

AU - Wingood, Gina M.

AU - DiClemente, Ralph

AU - Crosby, Richard A.

AU - Salazar, Laura F.

AU - Rose, Eve S.

AU - Sales, Jessica M.

PY - 2011/2/3

Y1 - 2011/2/3

N2 - Background: An important policy question is whether high-risk populations can be identified and prioritised for human papillomavirus (HPV) immunisation. Methods: Data collection included an audio computer-assisted survey interview and testing of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and HPV among 295 African-American adolescent females. Results: The results indicated that 43.1% tested positive for HPV. Logistic regression analyses indicated that HPV prevalence was not associated with other sexually transmissible infections (prevalence ratio (PR)=0.85, 95% confidence interval (CI)=0.51-1.41), unprotected vaginal sex (PR=1.04, 95% CI=0.56-1.92), having sex with an older male partner (PR=1.12, 95% CI=0.64-1.96), and having a casual partner (PR=0.89, 95% CI=0.54-1.48). Additionally, t-tests indicated that HPV prevalence was not associated with frequency of vaginal sex (t=0.17, P=0.87), protected sex (t=0.16, P=0.87), number of recent (t=0.40, P=0.69) or lifetime (t=1.45, P=0.15) sexual partners. However, those testing positive for HPV were younger (t=1.97, P=0.05) and reported current use of birth control pills (PR=2.38, 95% CI=1.00-5.63). Conclusions: It may not be possible to identify those with elevated risk of HPV acquisition. Thus, HPV vaccination, regardless of risk indicators, may be the most efficacious public health strategy.

AB - Background: An important policy question is whether high-risk populations can be identified and prioritised for human papillomavirus (HPV) immunisation. Methods: Data collection included an audio computer-assisted survey interview and testing of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and HPV among 295 African-American adolescent females. Results: The results indicated that 43.1% tested positive for HPV. Logistic regression analyses indicated that HPV prevalence was not associated with other sexually transmissible infections (prevalence ratio (PR)=0.85, 95% confidence interval (CI)=0.51-1.41), unprotected vaginal sex (PR=1.04, 95% CI=0.56-1.92), having sex with an older male partner (PR=1.12, 95% CI=0.64-1.96), and having a casual partner (PR=0.89, 95% CI=0.54-1.48). Additionally, t-tests indicated that HPV prevalence was not associated with frequency of vaginal sex (t=0.17, P=0.87), protected sex (t=0.16, P=0.87), number of recent (t=0.40, P=0.69) or lifetime (t=1.45, P=0.15) sexual partners. However, those testing positive for HPV were younger (t=1.97, P=0.05) and reported current use of birth control pills (PR=2.38, 95% CI=1.00-5.63). Conclusions: It may not be possible to identify those with elevated risk of HPV acquisition. Thus, HPV vaccination, regardless of risk indicators, may be the most efficacious public health strategy.

KW - adolescents

KW - African-American

KW - human papillomavirus

UR - http://www.scopus.com/inward/record.url?scp=79251603894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251603894&partnerID=8YFLogxK

U2 - 10.1071/SH10107

DO - 10.1071/SH10107

M3 - Article

C2 - 21371396

AN - SCOPUS:79251603894

VL - 8

SP - 125

EP - 127

JO - Sexual Health

JF - Sexual Health

SN - 1448-5028

IS - 1

ER -